- Home
- KWE vs KTTA Comparison
KWE vs KTTA Comparison
Compare KWE & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KWE
- KTTA
- Stock Information
- Founded
- KWE 2017
- KTTA 2020
- Country
- KWE Canada
- KTTA United States
- Employees
- KWE N/A
- KTTA N/A
- Industry
- KWE
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- KWE
- KTTA Health Care
- Exchange
- KWE Nasdaq
- KTTA Nasdaq
- Market Cap
- KWE 2.3M
- KTTA 2.8M
- IPO Year
- KWE N/A
- KTTA 2021
- Fundamental
- Price
- KWE $5.80
- KTTA $0.89
- Analyst Decision
- KWE
- KTTA
- Analyst Count
- KWE 0
- KTTA 0
- Target Price
- KWE N/A
- KTTA N/A
- AVG Volume (30 Days)
- KWE 89.8K
- KTTA 2.3M
- Earning Date
- KWE 05-16-2025
- KTTA 05-15-2025
- Dividend Yield
- KWE N/A
- KTTA N/A
- EPS Growth
- KWE N/A
- KTTA N/A
- EPS
- KWE N/A
- KTTA N/A
- Revenue
- KWE $2,115,849.00
- KTTA N/A
- Revenue This Year
- KWE N/A
- KTTA N/A
- Revenue Next Year
- KWE N/A
- KTTA N/A
- P/E Ratio
- KWE N/A
- KTTA N/A
- Revenue Growth
- KWE 121.88
- KTTA N/A
- 52 Week Low
- KWE $3.86
- KTTA $0.79
- 52 Week High
- KWE $243.60
- KTTA $7.50
- Technical
- Relative Strength Index (RSI)
- KWE 55.89
- KTTA 38.94
- Support Level
- KWE $4.89
- KTTA $0.87
- Resistance Level
- KWE $5.90
- KTTA $0.95
- Average True Range (ATR)
- KWE 0.43
- KTTA 0.07
- MACD
- KWE 0.07
- KTTA 0.01
- Stochastic Oscillator
- KWE 65.47
- KTTA 40.41
About KWE KWESST Micro Systems Inc.
KWESST Micro Systems Inc develops and commercializes next-generation tactical systems. The company offers breakthrough technology in lethal and non-lethal systems with broad application, including law enforcement and personal defence, modernized digitization of tactical forces for shared situational awareness and targeting, and counter-measures against threats such as drones, lasers and electronic detection.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).